| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| George I Papakostas, Stephen M Stahl, Alok Krishen, Cheryl A Seifert, Vivian L Tucker, Elizabeth P Goodale, Maurizio Fav. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. The Journal of clinical psychiatry. vol 69. issue 8. 2008-10-15. PMID:18605812. |
efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. |
2008-10-15 |
2023-08-12 |
Not clear |
| George I Papakostas, Stephen M Stahl, Alok Krishen, Cheryl A Seifert, Vivian L Tucker, Elizabeth P Goodale, Maurizio Fav. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. The Journal of clinical psychiatry. vol 69. issue 8. 2008-10-15. PMID:18605812. |
the goal of this work was to compare the efficacy of the norepinephrine and dopamine reuptake inhibitor bupropion with the selective serotonin reuptake inhibitors (ssris) in the treatment of major depressive disorder with high levels of anxiety (anxious depression). |
2008-10-15 |
2023-08-12 |
Not clear |
| I G Sil'ki. [Characteristics of the hippocampal formation functioning during wakefulness and paradoxical sleep]. Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova. vol 58. issue 3. 2008-10-10. PMID:18689238. |
in view of the available published data concerning various concentration of neuromodulators in the brain during paradoxical sleep and wakefulness and the evidence for the influences of neuromodulators on efficiency of synaptic inputs to hippocampal neurons it is concluded that during paradoxical sleep, increase in concentrations of acetylcholine, cortisol, and dopamine and simultaneous decrease in serotonin and noradrenaline levels could synergistically lead to essential depression of efficacy of synaptic transmission in the polysynaptic pathway through the hippocampus (i.e. |
2008-10-10 |
2023-08-12 |
Not clear |
| Ganesh Shanmugam, Blaine Kent, Turki Alsaiwadi, Roger Basket. Serotonin syndrome following cardiac surgery. Interactive cardiovascular and thoracic surgery. vol 7. issue 4. 2008-10-09. PMID:18334520. |
selective serotonin reuptake inhibitors (ssris) are widely used to treat depression. |
2008-10-09 |
2023-08-12 |
Not clear |
| Roshan Cools, Oliver J Robinson, Barbara Sahakia. Acute tryptophan depletion in healthy volunteers enhances punishment prediction but does not affect reward prediction. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 9. 2008-10-08. PMID:17940553. |
furthermore, the finding highlights the importance of central 5-ht in resilience to adversity and may have implications for a variety of neuropsychiatric disorders including depression and anxiety. |
2008-10-08 |
2023-08-12 |
human |
| F Haghighi, H Bach-Mizrachi, Y Y Huang, V Arango, S Shi, A J Dwork, G Rosoklija, H T Sheng, I Morozova, J Ju, J J Russo, J J Man. Genetic architecture of the human tryptophan hydroxylase 2 Gene: existence of neural isoforms and relevance for major depression. Molecular psychiatry. vol 13. issue 8. 2008-10-08. PMID:18180764. |
impaired brain serotonin neurotransmission is a potential component of the diathesis of major depression. |
2008-10-08 |
2023-08-12 |
human |
| M G Uzbekov, N M Maksimova, E Iu Misionzhnik, O P Vetrogradov. [Dynamics of biochemical parameters in patients with anxious depression treated with serotonergic antidepressants with different mechanisms of action]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 108. issue 2. 2008-10-07. PMID:18427501. |
the aim of the study was to compare the dynamics of some biochemical parameters in patients with anxious depression treated with tianeptine (coaxil) - serotonin reuptake enhancer and sertraline (zofort) - selective serotonin reuptake inhibitor. |
2008-10-07 |
2023-08-12 |
human |
| M G Uzbekov, N M Maksimova, E Iu Misionzhnik, O P Vetrogradov. [Dynamics of biochemical parameters in patients with anxious depression treated with serotonergic antidepressants with different mechanisms of action]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 108. issue 2. 2008-10-07. PMID:18427501. |
an analysis of the biochemical profiles revealed the changes in opposite directions of all investigated parameters for antidepressants with different effects on serotonin reuptake though both tianeptine and sertraline were effective in the treatment of anxious depression. |
2008-10-07 |
2023-08-12 |
human |
| Xénia Gond. [The serotonin transporter gene and personality: association of the 5-HTTLPR s allele, anxiety, depression and affective temperaments]. Orvosi hetilap. vol 149. issue 33. 2008-10-03. PMID:18687577. |
[the serotonin transporter gene and personality: association of the 5-httlpr s allele, anxiety, depression and affective temperaments]. |
2008-10-03 |
2023-08-12 |
human |
| I M Goodyer, B Dubicka, P Wilkinson, R Kelvin, C Roberts, S Byford, S Breen, C Ford, B Barrett, A Leech, J Rothwell, L White, R Harringto. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial. Health technology assessment (Winchester, England). vol 12. issue 14. 2008-09-30. PMID:18462573. |
a randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. |
2008-09-30 |
2023-08-12 |
Not clear |
| S G Butler, M J Meega. Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter. Current medicinal chemistry. vol 15. issue 17. 2008-09-26. PMID:18673223. |
the clinical selective serotonin reuptake inhibitors (ssris) have been shown to be among the most effective therapies in the treatment of depression. |
2008-09-26 |
2023-08-12 |
Not clear |
| Karen C Weber, Káthia M Honório, Adriano D Andricopulo, Albérico B F Da Silv. Two-dimensional QSAR studies on arylpiperazines as high-affinity 5-HT(1A) receptor ligands. Medicinal chemistry (Shariqah (United Arab Emirates)). vol 4. issue 4. 2008-09-25. PMID:18673144. |
moreover, 5-ht(1a) receptor levels have been shown to be altered in patients suffering from major depression. |
2008-09-25 |
2023-08-12 |
Not clear |
| Matthäus Willeit, Harald H Sitte, Nikolaus Thierry, Klaus Michalek, Nicole Praschak-Rieder, Peter Zill, Dietmar Winkler, Werner Brannath, Michael B Fischer, Brigitta Bondy, Siegfried Kasper, Ernst A Singe. Enhanced serotonin transporter function during depression in seasonal affective disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 7. 2008-09-24. PMID:17882235. |
enhanced serotonin transporter function during depression in seasonal affective disorder. |
2008-09-24 |
2023-08-12 |
human |
| Matthäus Willeit, Harald H Sitte, Nikolaus Thierry, Klaus Michalek, Nicole Praschak-Rieder, Peter Zill, Dietmar Winkler, Werner Brannath, Michael B Fischer, Brigitta Bondy, Siegfried Kasper, Ernst A Singe. Enhanced serotonin transporter function during depression in seasonal affective disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 7. 2008-09-24. PMID:17882235. |
decreased synaptic serotonin during depressive episodes is a central element of the monoamine hypothesis of depression. |
2008-09-24 |
2023-08-12 |
human |
| Fili Fazzino, Carol Montes, Mary Urbina, Isabel Carreira, Lucimey Lim. Serotonin transporter is differentially localized in subpopulations of lymphocytes of major depression patients. Effect of fluoxetine on proliferation. Journal of neuroimmunology. vol 196. issue 1-2. 2008-09-24. PMID:18462811. |
serotonin transporter is differentially localized in subpopulations of lymphocytes of major depression patients. |
2008-09-24 |
2023-08-12 |
human |
| Cornelle W Noorlander, Frederique F T Ververs, Peter G J Nikkels, Cees J A van Echteld, Gerard H A Visser, Marten P Smid. Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PloS one. vol 3. issue 7. 2008-09-24. PMID:18716672. |
in the treatment of depression and anxiety disorders, selective serotonin reuptake inhibitors (ssris) are the most frequently prescribed drugs, while it is largely unknown whether this medication affects the development of the central nervous system of the fetus. |
2008-09-24 |
2023-08-12 |
Not clear |
| T H Roobol, J K Buitelaa. [A place for SSRIs in the treatment of severely depressed children and adolescents]. Nederlands tijdschrift voor geneeskunde. vol 152. issue 31. 2008-09-15. PMID:18727599. |
although in the past there were objections against the use of selective serotonin reuptake inhibitors (ssris) for the treatment of depression in children and adolescents, recent studies have shown that ssris, in particular fluoxetine, are effective against depression in this age group. |
2008-09-15 |
2023-08-12 |
Not clear |
| Yutaro Suzuki, Naoki Fukui, Kazushi Sawamura, Takuro Sugai, Junzo Watanabe, Shin Ono, Yoshimasa Inoue, Vural Ozdemir, Toshiyuki Somey. Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depression. Journal of clinical psychopharmacology. vol 28. issue 3. 2008-09-11. PMID:18480690. |
therapeutic drug monitoring studies of selective serotonin reuptake inhibitor (ssri) antidepressants thus far failed to identify a clear concentration-response relationship in major depression. |
2008-09-11 |
2023-08-12 |
Not clear |
| D D Luo, S C An, X Zhan. Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress. Brain research bulletin. vol 77. issue 1. 2008-09-11. PMID:18579108. |
involvement of hippocampal serotonin and neuropeptide y in depression induced by chronic unpredicted mild stress. |
2008-09-11 |
2023-08-12 |
rat |
| D D Luo, S C An, X Zhan. Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress. Brain research bulletin. vol 77. issue 1. 2008-09-11. PMID:18579108. |
accumulated evidence indicates a role of the hippocampal 5-hydroxy-tryptamine (5-ht) and neuropeptide y (npy) in the response to stress and modulation of depression, but it is unclear whether and how the hippocampal 5-ht and npy systems make contributions to chronic unpredicted mild stress (cums)-induced depression. |
2008-09-11 |
2023-08-12 |
rat |